1. dcjl4501
2. 143sam
3. stephenlove7
4. lodiboomer32
5. hankj8247
1.lodiboomer32 01/30/2018
SeeThruEquity Initiates Coverage on AzurRx BioPharma, Inc. (NASDAQ CM: AZRX) with a Price Target of $10.00
2.143sam 04/18/2018
AzurRx BioPharma Announces Positive Preclinical Data with AZX1103
3.dcjl4501 01/30/2018
You sure? Up 14%
4.hankj8247 01/30/2018
SeeThruEquity is chump change
5.stephenlove7 02/12/2018
AzurRx BioPharma Announces Enrollment of Three New Patients for its Phase IIa Study of MS1819-SD
6.dcjl4501 01/18/2018
AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of MS1819-SD for Exocrine Pancreatic Insufficiency
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW